Sensex and nifty record high
Context: Sensex and Nifty are again touching record highs, driven mainly by a narrow set of large-cap heavyweights such as leading banks and Reliance. About Sensex and Nifty Record High:Read More
Context: Sensex and Nifty are again touching record highs, driven mainly by a narrow set of large-cap heavyweights such as leading banks and Reliance. About Sensex and Nifty Record High:Read More
Context: Prime Minister Narendra Modi unveiled a 77-feet bronze statue of Lord Rama at the Shree Samsthan Gokarn Partagali Jeevottam Math in Goa. He also visited Udupi evoked the legacyRead More
1. What’s the Issue? (Context) India’s disaster response framework—built around the Disaster Management Act, 2005—has recently drawn attention for becoming highly centralised, especially during large-scale disasters like COVID-19, cyclones, floods,Read More
1. What is the News? The Government of India has approved a new scheme to promote domestic manufacturing of Sintered Rare Earth Permanent Magnets (REPM) to reduce import dependence andRead More
1. What is the News? The United Nations ESCAP released the Asia-Pacific Disaster Report 2025, titled “Rising Heat, Rising Risk”, warning that extreme heat is becoming the fastest-growing and mostRead More
➤ What is the News? Justice Surya Kant has been sworn in as the 53rd Chief Justice of India (CJI) on 24 November 2025. ➤ Who Administered the Oath? PresidentRead More
What is the News? The Ministry of Road Transport & Highways released the draft of Bharat NCAP 2.0, proposing tougher car-safety testing norms and a new star-rating system. It isRead More
What is the G20 Summit 2025? The G20 Summit 2025 will be hosted by South Africa. This is the first time South Africa is hosting the G20 Summit since joiningRead More
Context: A wild tiger has permanently settled in Gujarat’s Ratanmahal Wildlife Sanctuary for the first time in decades, staying for nine continuous months—an unprecedented wildlife milestone for the state. This marks Gujarat asRead More
Context: India has launched its first indigenous CRISPR-based gene therapy for Sickle Cell Disease, named BIRSA 101, marking a major milestone in affordable genomic medicine. About BIRSA 101 Gene Therapy: What it is? BIRSARead More